BE711303A - - Google Patents

Info

Publication number
BE711303A
BE711303A BE711303DA BE711303A BE 711303 A BE711303 A BE 711303A BE 711303D A BE711303D A BE 711303DA BE 711303 A BE711303 A BE 711303A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE711303A publication Critical patent/BE711303A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D281/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02Seven-membered rings
    • C07D281/04Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16[b, f]-condensed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02Seven-membered rings
    • C07D267/08Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/20[b, f]-condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE711303D 1967-02-27 1968-02-26 BE711303A (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61901567A 1967-02-27 1967-02-27

Publications (1)

Publication Number Publication Date
BE711303A true BE711303A (en:Method) 1968-08-26

Family

ID=24480094

Family Applications (1)

Application Number Title Priority Date Filing Date
BE711303D BE711303A (en:Method) 1967-02-27 1968-02-26

Country Status (11)

Country Link
AT (2) AT279620B (en:Method)
BE (1) BE711303A (en:Method)
CA (1) CA979441A (en:Method)
CH (1) CH502371A (en:Method)
DE (1) DE1670032A1 (en:Method)
DK (1) DK130246B (en:Method)
ES (2) ES350979A1 (en:Method)
FR (2) FR1575597A (en:Method)
GB (1) GB1218045A (en:Method)
NL (1) NL6802729A (en:Method)
SE (1) SE353724B (en:Method)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ196898A (en) * 1980-04-25 1984-05-31 Hoffmann La Roche Topical anti-inflammatory composition containing a 10-piperazine-dibenzo(b,f)thiepin or oxepin
US7863441B2 (en) * 2003-09-23 2011-01-04 Fermion Oy Preparation of quetiapine
ATE496038T1 (de) * 2003-09-23 2011-02-15 Fermion Oy Verfahren zur herstellung von quetiapin
JP2007534656A (ja) 2003-12-22 2007-11-29 アカディア ファーマシューティカルズ,インコーポレーテッド ムスカリンアゴニストとしてのアミノ置換ジアリール[a,d]シクロヘプテン類似体および精神神経疾患の治療方法
GB0516603D0 (en) * 2005-08-12 2005-09-21 Sandoz Ag Processes for the preparation of organic compounds useful as serotonin receptor antagonists
CA2678897C (en) * 2007-03-15 2015-10-20 Aryx Therapeutics, Inc. Dibenzo[b,f][1,4]oxazapine compounds

Also Published As

Publication number Publication date
FR7049M (en:Method) 1969-06-16
ES366784A1 (es) 1971-12-01
DK130246C (en:Method) 1975-06-23
AT279620B (de) 1970-03-10
AT279628B (de) 1970-03-10
ES350979A1 (es) 1969-12-01
CA979441A (en) 1975-12-09
SE353724B (en:Method) 1973-02-12
DK130246B (da) 1975-01-27
GB1218045A (en) 1971-01-06
NL6802729A (en:Method) 1968-08-28
DE1670032A1 (de) 1971-02-25
FR1575597A (en:Method) 1969-07-25
CH502371A (de) 1971-01-31

Similar Documents

Publication Publication Date Title
AU425114B2 (en:Method)
DK130246C (en:Method)
AU416737B2 (en:Method)
AU342066A (en:Method)
AU2528767A (en:Method)
AU3151267A (en:Method)
AU3189468A (en:Method)
AU2977667A (en:Method)
AU610966A (en:Method)
AU2454867A (en:Method)
BE509738A (en:Method)
BE706245A (en:Method)
BE692374A (en:Method)
BE711860A (en:Method)
BE692332A (en:Method)
BE692199A (en:Method)
BE692198A (en:Method)
BE614676A (en:Method)
BE609934A (en:Method)
BE692409A (en:Method)
BE711338A (en:Method)
BE711058A (en:Method)
BE483855A (en:Method)
BE477645A (en:Method)
BE426053A (en:Method)